Table 1.
Pancreatic Cancer | Prostate Cancer | |||||||
---|---|---|---|---|---|---|---|---|
Germline [25,35,59,60] | Somatic [25,36,37,63] | Germline [48,61,62] | Somatic [61,63,64] | |||||
Gene | Range | Max | Range | Max | Range | Max | Range 1 | Max |
BRCA1/2 | 0.9–5 | 5 | 0.9–4.8 | 4.80 | 0.3–8.6 | 8.60 | 0.6–15.2 | 15.2 |
ATM | 2–3.09 | 2.2–9 | 1.59–2.3 | 1.9–7.3 | ||||
ATR | 0.2 | 0.29 | ||||||
BRIP1 | 0.22–1 | 0.48–1 | 0.28–0.45 | |||||
CHEK1-2 | 0.3–2.2 | 0.2–0.6 | 1.87–4.1 | 0.9–1.9 | ||||
FANCA | 1.04 | 0.6 | 3 | |||||
MMR | 0.39–1.2 | 0.8 | 0.14–1.7 | 3–6 | ||||
NBN | 0.2–0.59 | 0.29–2 | ||||||
PALB2 | 0.1–0.97 | 0.2–1.2 | 0.45–0.56 | 0.4–2 | ||||
RAD50 | 0.3–0.36 | 0.5 | 1 | |||||
RAD51 | 0.35 2 | 0.14–0.57 2,3 | 0.54 2,3 | |||||
Non-BRCA1/2 | 11 | 13.7 | 12.07 | 21.74 | ||||
TOTAL | 16 | 18.5 | 20.67 | 36.94 |
Frequencies are reported as percentages. 1 mCRPC, 2 RAD51C, 3 RAD51D.